The company got the nod to manufacture and market apalutamide tablets, 60 mg, the generic equivalent of Erleada tablets, 60 ...

to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila, in accordance with the Centre's order, is expected to supply a total of one crore ZyCov-D doses ...

The uptick in the Zydus Life shares came after the company received final approval from the USFDA to manufacture Eluxadoline Tablets, 75 mg and 100 mg ...

Zydus Lifesciences Ltd. has received final nod from the United States Food and Drug Administration to manufacture 60 mg Apalutamide tablets, according to an exchange filing on Tuesday.

The approval covers Apalutamide tablets of 60 mg strength, the company said in a regulatory filing. The drug will be ...

Eluxadoline tablets will be produced at Zydus Lifesciences Ltd (SEZ) in Ahmedabad, the company said in an exchange filing.

Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive ...